SOURCE: HealthSonix, Inc.

April 13, 2007 11:55 ET

HealthSonix President to Be Interviewed "Live" on Christian Financial Radio Network on Monday

IRVINE, CA -- (MARKET WIRE) -- April 13, 2007 -- HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) announced today that its president, Michael Ivezic, will be interviewed on Christian Traders --, the internet's fastest growing faith-based online investment community, in partnership with CFRN -- the world's first Christian Financial Radio Network. The interview will be broadcast live at 1:30 p.m. Eastern Daylight Time, Monday, April 16, 2007 and the investors can tune in online at

During the interview, Mr. Ivezic will answer questions about management's review of operations. He will discuss in detail results of the latest clinical trials, international distribution contracts, new product development and marketing programs planned for the new enSonix@home personal medical device, AquaSonix Therapy expansion programs and major drug company and hospital partnerships.

CFRN -- -- originally developed and produced for the niche market of Christian investors, has surprised industry insiders by attracting a worldwide audience of loyal listeners from all walks of life ranging from individual investors to fund managers. Listeners are drawn by the dynamic blend of popular contemporary Christian music, live market updates, corporate interviews, hourly spiritual encouragement, and strong conservative perspective. CFRN has forged a strategic relationship with The Hunger Site, and has set a goal of eradicating world hunger. Think it's impossible? Visit to learn how you can help without spending a dime.

Disclaimer: Christian Traders does not accept cash, stock, warrants, or promises thereof, to select or profile any company.

HealthSonix, Inc. (PINKSHEETS: HSXI) (FRANKFURT: H7S) is a publicly traded medical technology company. The Company's core offerings are based on proprietary, patent pending medical technologies that use sound pulses to administer sub-sensory micro vibration to the human body. Precisely formatted low frequency sound pulses are 80% effective in treating the pain of many diseases, particularly arthritis. All treatments and products are safe, non-invasive and have no known side effects.

Note: A number of statements contained in this report are forward-looking statements, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions, the ability to secure additional sources of financing, the ability to reduce operating expenses and other factors not set forth herein. The actual results that the Company may achieve may differ materially from any forward-looking statements due to such risks and uncertainties.

Contact Information